The readiness with which many organisms develop resistance to streptomycin is well recognized; Willcox (1953) ventured to predict that "should streptomycin be widely used for gonorrhoea it is possible that its efficiency may decline".
At the Liverpool Royal Infirmary during the past 4 years routine treatment of male patients suffering from gonorrhoea has been by a single injection of streptomycin 0 5 g. During the 3 years 1954-56, 687 cases were so treated. Failures totalled 34 (4 9 per cent.), but when the 3 years are examined separately (Table) , it will be seen that the failure rate has increased sharply from 2 3 per cent.
in 1954 to 7 per cent. in 1956. be a recurrence of urethral discharge and gonococci would be found on microscopical examination. When, as in three patients, relapse does not occur until 2 weeks or more after treatment, it is tempting to invoke re-infection as the explanation, but the following case history points very strongly to the view that relapse may not be apparent for several weeks.
Case Report
A man aged 19, with no previous history of venereal disease, gave a history of exposure to infection one week before he was seen on June 10, 1955. He complained of slight discharge for 3 days.
Examination.-There was a purulent urethral discharge. Gonococci were present on microscopic examination.
Treatment.-Streptomycin 0 5 g. stat., Sulphathiazole Ig. four times daily for 5 days.
Progress.--3.6.55 and 17.6.55. No urethral discharge, urine clear.
He was instructed to report in 2 weeks, but returned to the clinic after 3 days and stated that he thought he had noticed a discharge 2 days previously. He was reexamined but no urethral discharge was seen and his urine was clear. He was again instructed to report in a fortnight, but returned 9 days later once more complaining of a discharge. No discharge could be seen, but unfortunately he had recently urinated.
After a further 2 days he returned to the clinic with a purulent urethral discharge with gonococci present. He was given a further injection of streptomycin 0 5 g. and returned 3 days later still with a persistent discharge. Gonococci were present and he was then given an injection of streptomycin I g., again without effect.
Two days later 300,000 units P.A.M. gave prompt and lasting benefit.
In addition to the above, four other patients who had failed to respond to streptomycin 0-5 g. were re-treated after 48 Evidence that streptomycin resistant gonorrhoea may be increasing has already been reported from Italy (Chiarenza, 1954) . There is now evidence to suggest that the same thing may be occurring in Great Britain. Fortunately, we possess in penicillin a readily available and effective alternative.
Summary
Our experience in the treatment of gonorrhoea in the male with a single injection of streptomycin 0 5 g. is reviewed.
An overall failure rate of 4-9 per cent. is recorded and the varied course of failed cases is described.
Evidence is presented suggesting that streptomycin resistance is increasing in Great Britain. 
